Voloridge Investment Management
PRTA icon

Voloridge Investment Management’s Prothena Corp PRTA Stock Holding History

Voloridge Investment Management’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-145,551
Closed -$7.19M – 1643
2021
Q4 		$7.19M Buy
145,551
+18,294
+14% +$1.01M 0.04% 571
2021
Q3 		$9.06M Buy
127,257
+51,596
+68% +$3.2M 0.06% 465
2021
Q2 		$3.89M Buy
+75,661
New +$2.36M 0.03% 733

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Voloridge Investment Management's PRTA Position: Q1 2022 in Review

Voloridge Investment Management sold out of Prothena Corp (PRTA) in Q1 2022, closing a stake of 145,551 shares — an estimated $7.19M sold.

Voloridge Investment Management first reported a position in PRTA in Q2 2021 and held it in 3 quarters. The position peaked at $9.06M in Q3 2021. 174 funds tracked by Wall St. Rank hold PRTA as of Q1 2022.

  • Voloridge Investment Management reported no remaining Prothena Corp position as of Q1 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 145,551 Prothena Corp shares in Q1 2022, an estimated $7.19M.
  • Voloridge Investment Management first reported a position in Prothena Corp in Q2 2021 and held it in 3 quarters.
  • Voloridge Investment Management's Prothena Corp position peaked at $9.06M in Q3 2021.
  • 174 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.